Sutro Biopharma (STRO) Cash from Investing Activities Growth (3y) (2020 - 2025)
Sutro Biopharma (STRO) Cash from Investing Activities Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -29.84% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 38.24% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -22.09% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Sutro Biopharma | 204.80 Mn | 63.37 Mn | - | 35.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.61% |
| Sep 30, 2025 | 35.95% |
| Jun 30, 2025 | -62.24% |
| Mar 31, 2025 | -35.59% |
| Dec 31, 2024 | 61.47% |
| Sep 30, 2024 | 307.56% |
| Jun 30, 2024 | -150.29% |
| Mar 31, 2024 | 36.20% |
| Dec 31, 2023 | -51.65% |
| Sep 30, 2023 | -628.86% |
| Jun 30, 2023 | 46.71% |
| Mar 31, 2023 | 17.45% |
| Dec 31, 2022 | -89.17% |
| Sep 30, 2022 | -115.11% |
| Jun 30, 2022 | 73.38% |
| Mar 31, 2022 | 34.30% |
| Dec 31, 2021 | 117.31% |
| Sep 30, 2021 | 69.85% |
| Jun 30, 2021 | 448.73% |
| Mar 31, 2021 | -594.12% |